Dabrafenib, Trametinib Beneficial in Resected Melanoma

Rate of relapse - free survival up for resected stage III melanoma with BRAF V600E, V600K mutations
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Dermatology, Oncology, Pharmacy, Conference News, Source Type: news